WO2023082626A1 - Method for preparing oyster shell calcium granules - Google Patents

Method for preparing oyster shell calcium granules Download PDF

Info

Publication number
WO2023082626A1
WO2023082626A1 PCT/CN2022/098166 CN2022098166W WO2023082626A1 WO 2023082626 A1 WO2023082626 A1 WO 2023082626A1 CN 2022098166 W CN2022098166 W CN 2022098166W WO 2023082626 A1 WO2023082626 A1 WO 2023082626A1
Authority
WO
WIPO (PCT)
Prior art keywords
calcium carbonate
sucrose
calcium
granules
solution
Prior art date
Application number
PCT/CN2022/098166
Other languages
French (fr)
Chinese (zh)
Inventor
张壹
沈浩
游雪丹
刘森
黄介
周帮建
蒋永财
李兰
杜梅霞
陈小禹
韦婷婷
莫小霞
Original Assignee
重庆华森制药股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 重庆华森制药股份有限公司 filed Critical 重庆华森制药股份有限公司
Publication of WO2023082626A1 publication Critical patent/WO2023082626A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/618Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Definitions

  • the invention belongs to the field of pharmaceutical preparations, and in particular relates to a preparation method of oyster calcium carbonate granules.
  • Calcium is one of the important elements of the human body and has very important physiological and biochemical functions.
  • the content of calcium in the human body accounts for 1.5%-2% of the total body weight, of which bones and teeth account for about 99%, and body fluids and soft tissues account for 1%.
  • Calcium is not only the main substance that constitutes bones, but also participates in the metabolism of bones, and is necessary to maintain nerve and muscle functions. It also plays a role in maintaining normal heart, kidney, lung and blood coagulation functions, as well as the permeability of cell membranes and capillaries. It can also regulate the secretion and storage of neurotransmitters and hormones, the uptake and utilization of amino acids, and the absorption of vitamin B12.
  • An important mechanism for human living cells to obtain energy is the transmembrane movement of calcium.
  • the calcium content of the cell membrane is 500 times higher than that of the intracellular calcium.
  • Neuromuscular responses, blood coagulation, cell adhesion, nerve impulse conduction, heart rate maintenance, and cell secretion, contraction, excitation, diffusion, and differentiation all depend on this transmembrane movement.
  • Oyster calcium carbonate is widely used in European and American countries, and has been recorded in Chinese, American, British, and Japanese pharmacopoeias, and it is clinically used as a calcium supplement.
  • the effect of calcium supplementation depends on how much calcium is absorbed.
  • the absorption site of calcium is in the upper part of the small intestine, and the duodenum absorbs the fastest, but the absorption amount takes the longer ileum as the main absorption site of calcium.
  • the absorption of calcium is mainly through the active transport of the intestinal mucosa, except for a small amount of absorption by diffusion.
  • the absorption rate is different in different ages: the absorption rate of infants is the highest, 50%-60%; the absorption rate of teenagers is 35%-40%; the absorption rate of adults is lower, 15%-20%; the absorption rate of the elderly Only 10%.
  • the concentration of the drug in the blood is an important condition for the drug to exert and maintain its curative effect, and it is also the basis for evaluating the absorption of calcium supplements.
  • Oyster Calcium Carbonate is a regular calcium supplement for pregnant and lactating women, menopausal women, the elderly, etc.
  • the active ingredients of this product have extremely low solubility in water, and are prone to precipitation during storage and use.
  • calcium does not exist in an ion state, and it needs to be absorbed after being dissociated by gastric acid. This condition can be irritating to the stomach and can also affect calcium absorption.
  • "How to Correctly Choose Oral Calcium Agents" (“China rural Medicine", 1998, Vol. 26, No. 1, Page 17), summarizes the characteristics that high-quality calcium agents should have, including good solubility and high bioavailability.
  • how to improve the solubility of this product, reduce precipitation, and ensure the stability of quality indicators, so as to improve the calcium supplement effect of this product has been an unsolved problem that pharmaceutical researchers have been working hard on.
  • CN106943427A discloses a calcium carbonate particle composition and a preparation method thereof to solve the problems of poor solubility and easy precipitation of existing preparations.
  • the composition according to the scheme comprises: 100 parts of calcium carbonate, 3000-4500 parts of powdered sugar and 120-180 parts of acid source.
  • the method includes the following steps:
  • step (d) mixing the calcium carbonate granules obtained in step (b) and the acid granules obtained in step (c) to obtain the calcium carbonate granule composition.
  • the finished granules are divided into two parts, namely calcium carbonate granules and acid granules.
  • Calcium carbonate granules are made by adding water to sucrose to make syrup, then granulated with calcium carbonate and powdered sugar; acid granules are made by adding acid to water, and then granulated with the remaining sucrose.
  • the contact between calcium carbonate and acid source is avoided to a certain extent, which is beneficial to the stability of calcium carbonate, improving solubility and reducing precipitation.
  • step (c) that is, the acid particle drying step, adopts two methods: one is to dry for 5-60h at 25°C in a common drying oven; Dry with cold air for 1-20 minutes, then dry with hot air at 40-70°C for 10-20 minutes, then cool down to room temperature with cold air at 18-26°C.
  • the drying of acid particles takes a long time (drying at 25°C for 5-60 hours), or the operation is cumbersome (first cold air, then hot air, and finally cold air drying), which increases the difficulty of operation and increases the production cost, which is not conducive to commercialization Production.
  • the inventors found that the samples prepared by this method had two problems: 1.
  • the content uniformity of the finished product was poor, which may be due to the small proportion of the main drug of this product (about 2.5% ), the use of two-part granulation is related to the fact that the main ingredient is not easy to mix evenly; 2.
  • the results of further accelerated inspection and testing show that the acidity of the finished product has increased significantly.
  • Oyster calcium carbonate granules mostly adopt wet granulation process. Specifically, rocking granulation, shear granulation, one-step fluidized bed granulation, and a combination of different granulation methods can be used.
  • the inventor improved the technical solution disclosed in CN106943427A, replaced the granulation solvent with purified water to a certain concentration of ethanol, dissolved citric acid in ethanol and then granulated with sucrose, and found that the obtained granules It will appear light yellow when drying, and the color will deepen with the increase of citric acid dosage. According to this phenomenon, the inventor creatively mixed sucrose and citric acid in ethanol solution, and the mixed solution was used as binder, and then granulated. Through the study of ethanol concentration, the amount of dissolved sucrose, and the corresponding conditions, it was found that the finished product prepared by this granulation method has better content uniformity, good solubility, less precipitation, and stable pH value. Surprisingly, by monitoring the blood calcium concentration after taking it, the finished product made by this process has a better calcium supplement effect and can increase the blood calcium concentration faster.
  • the object of the present invention is to provide a kind of preparation method of oyster calcium carbonate particle, this method adopts wet shearing granulation process.
  • the outstanding substantive feature of this process is that ethanol is used as a solvent, and the entire prescription amount of citric acid and a specific amount of sucrose are dissolved in ethanol, and a specific temperature needs to be controlled during the dissolution.
  • a kind of preparation method of oyster calcium carbonate particle of the present invention comprises the following steps:
  • the further optimized technical scheme of the present invention can be:
  • the oyster calcium carbonate granule prescription contains parts by weight:
  • the prescription of oyster calcium carbonate granules contains parts by weight:
  • the prescription of the present invention may also contain other pharmaceutical excipients suitable for this dosage form, including pigments and essences, such as 0.1 part of tartrazine and 2.5 parts of orange essence.
  • oyster calcium carbonate and sucrose are pulverized and passed through a sieve of 80-100 mesh, preferably a sieve of 100 mesh, and the sieving treatment realizes the particle size control of the starting material and avoids material agglomeration.
  • a sieve of 80-100 mesh preferably a sieve of 100 mesh
  • Solution A prepared by dissolving citric acid and part of sucrose in ethanol solution acts as a binder during the preparation of this product. According to research, the amount of ethanol solution is 6.5% of the weight of the granulated material.
  • a small amount of ethanol can be added according to the state of the material, and then the granulation can be carried out. This is a problem that can be recognized and judged by ordinary technicians in pharmacy, and it will not have a major or decisive impact on the quality of this product.
  • the present invention uses ethanol as a solvent, and creatively dissolves the whole prescription amount of citric acid and part of sucrose in ethanol.
  • the ethanol concentration is obtained through screening and needs to be controlled at 20%-40%, and the preferred ethanol concentration is 30%.
  • the amount of sucrose dissolved in ethanol is determined after repeated screening, and the stability of this product can only be guaranteed if the amount reaches 6.5% of the weight of the granulated material.
  • the dosage is lower than 6.5%, there is no obvious difference in the quality of the finished product at day 0, but in the process of drug stability investigation, there will be problems of increased precipitation and increased pH value.
  • the preferred amount of sucrose dissolved in ethanol is 7.5% of the recipe amount.
  • the temperature of ethanol needs to be controlled at 40°C-60°C. Below 40°C, the material dissolves slowly, which is not conducive to production; above 60°C, the color of the prepared particles is prone to change, which needs to be avoided during the production process.
  • the finished product prepared by the method of the invention weakens the effect of citric acid and calcium carbonate, thereby having the characteristics of good solubility, less precipitation and stable pH value.
  • this method adopts wet granulation to fully mix and evenly, and the content uniformity of the finished product is better.
  • the blood calcium concentration can be increased faster and has a better calcium supplement effect.
  • increasing absorption and improving effects have always been the direction of continuous efforts of technicians.
  • the technical solution of the present invention is essentially characterized in that citric acid and a specific amount of sucrose are dissolved in an alcoholic solution for granulation, and a conventional wet granulation process is still adopted.
  • the production process is simple, the operation is easy, the cost is low, and it is suitable for large-scale industrial production.
  • the preparation method not only ensures the product quality in pharmacy, but also has better clinical application effect.
  • the present invention is undoubtedly a huge technical progress for the calcium supplement product of oyster calcium carbonate granules, and also has a significant improvement compared with the prior art.
  • Embodiment 1 oyster calcium carbonate granule prescription (parts by weight)
  • Solution A was prepared.
  • step 3 Add the prescription amount of oyster calcium carbonate and the remaining amount of sucrose into the high-efficiency wet granulator, stir at a low speed for 100 seconds, and mix well. Then add the solution A in step 2) with low-speed stirring and high-speed cutting. After adding solution A, high-speed stirring and high-speed cutting for 60 seconds to obtain wet particles.
  • the prepared granules are dried in a fluidized bed, and the air inlet temperature is controlled at about 60° C. during drying; the dried granules are sized with a pulverizing granulator.
  • Embodiment 2 oyster calcium carbonate granule prescription (parts by weight)
  • step 3 Add the prescription amount of oyster calcium carbonate and the remaining amount of sucrose into the high-efficiency wet granulator, stir at a low speed for 100 seconds, and mix well. Then add the solution A in step 2) with low-speed stirring and high-speed cutting. After adding solution A, high-speed stirring and high-speed cutting for 60 seconds to obtain wet particles.
  • the prepared granules are dried in a fluidized bed, and the air inlet temperature is controlled at about 60° C. during drying; the dried granules are sized with a pulverizing granulator.
  • Embodiment 3 oyster calcium carbonate granule prescription (weight part)
  • step 3 Add the prescription amount of oyster calcium carbonate and the remaining amount of sucrose into the high-efficiency wet granulator, stir at a low speed for 100 seconds, and mix well. Then add solution A in step 2) with low-speed stirring and high-speed cutting, and high-speed stirring and high-speed cutting for 60 seconds after solution A is added. After the granulation is completed, turn on low-speed stirring and high-speed cutting, then weigh 40% ethanol solution according to 1% of the weight of the granulated material and add it, after adding the ethanol solution, high-speed stirring and high-speed cutting for 30 seconds, that is, wet granules.
  • the prepared granules are dried in a fluidized bed, and the air inlet temperature is controlled at about 60° C. during drying; the dried granules are sized with a pulverizing granulator.
  • Comparative Example 1 According to the content disclosed in Example 1 of CN106943427A, a sample was prepared.
  • Comparative test the finished calcium carbonate granules prepared in Examples 1-3 of the present invention and the finished calcium carbonate granules prepared in the comparative examples were detected.
  • testing refer to the national drug standard WS-10001-(HD-1037)-2002 for testing.
  • Acidity Take an appropriate amount of fine powder of this product (approximately equivalent to 50mg of calcium), add 100ml of water, shake for 10 minutes, and filter. Get filtrate, measure according to law (Chinese Pharmacopoeia edition in 2000 two appendix VI H), pH value should be 4.5-6.5.
  • Solubility Take 10g of this product, heat 200ml of water, stir for 5 minutes, it should be completely dissolved or slightly turbid or evenly suspended, but there should be no foreign matter such as burnt debris.
  • Content uniformity take 10 bags of the finished product, check the content of each bag according to the detection method of the content item, and calculate the RSD.
  • Example 1 100.2 5.06 melt all, clear 0.96%
  • Example 2 99.3 5.12 melt all, clear 0.83%
  • the content uniformity of the samples of the examples is obviously better than that of the samples of the comparative examples.
  • the sample of the embodiment has better acidity stability, and the solubility index is also better than that of the sample of the comparative example.
  • the finished product of oyster calcium carbonate granules (calculated as calcium 50 mg/bag) prepared in Example 2 and Comparative Example 1 is used for calcium supplementation crowds, blood calcium concentration is monitored before and after taking, and clinical application effect is evaluated.
  • Volunteer grouping and methods Screen 98 cases who are suitable for calcium supplementation or have calcium supplementation needs, and randomly divide them into two groups, 49 cases in each group.
  • Group I took the oyster calcium carbonate granules of Example 2
  • Group II took the oyster calcium carbonate granules of Comparative Example 1.
  • the two groups took the same method: take it orally, two bags at a time, three times a day, and take it with warm water. Both groups were taken continuously for 8 weeks. Venous blood was drawn at the following time points for blood calcium concentration monitoring, and the data was recorded and analyzed: before taking, after taking for 4 weeks, after taking for 6 weeks, and after taking for 8 weeks.

Abstract

A method for preparing oyster shell calcium granules, the method comprising the following steps: dissolving a prescribed amount of citric acid and some sucrose in an ethanol solution to prepare a solution A, adding a prescribed amount of oyster shell calcium and the remaining amount of sucrose to a wet granulator, then adding the solution A, performing shearing and granulating, and drying and size grading same. The prepared oyster shell calcium granules have the characteristics of good content uniformity, good solubility, low precipitation, stable pH value, etc.

Description

一种牡蛎碳酸钙颗粒的制备方法A kind of preparation method of oyster calcium carbonate particle 技术领域technical field
本发明属于药物制剂领域,具体涉及一种牡蛎碳酸钙颗粒的制备方法。The invention belongs to the field of pharmaceutical preparations, and in particular relates to a preparation method of oyster calcium carbonate granules.
背景技术Background technique
钙是人体重要的元素之一,具有十分重要的生理、生化功能。人体中钙的含量占总体重的1.5%-2%,其中骨骼和牙齿约占99%,体液和软组织占1%。钙不仅是构成骨骼的主要物质,参与骨骼的新陈代谢,而且是保持神经、肌肉功能所必须的,对维持正常的心、肾、肺和凝血功能以及细胞膜和毛细血管的通透性也都起着重要的作用,还能调节神经递质和激素的分泌和储存、氨基酸的摄取和利用、维生素B12的吸收等。人体活细胞获得能量的重要机制是钙的跨膜运动,平常细胞膜的含钙量比细胞内含钙量高500倍。神经肌肉反应、血液的凝固、细胞的粘着、神经冲动的传导、心率的维护以及细胞的分泌、收缩、兴奋、扩散、分化都依赖于这种跨膜运动。牡蛎碳酸钙广泛应用于欧美各国,己收载于中国、美国、英国、日本药典,临床上用作补钙制剂。Calcium is one of the important elements of the human body and has very important physiological and biochemical functions. The content of calcium in the human body accounts for 1.5%-2% of the total body weight, of which bones and teeth account for about 99%, and body fluids and soft tissues account for 1%. Calcium is not only the main substance that constitutes bones, but also participates in the metabolism of bones, and is necessary to maintain nerve and muscle functions. It also plays a role in maintaining normal heart, kidney, lung and blood coagulation functions, as well as the permeability of cell membranes and capillaries. It can also regulate the secretion and storage of neurotransmitters and hormones, the uptake and utilization of amino acids, and the absorption of vitamin B12. An important mechanism for human living cells to obtain energy is the transmembrane movement of calcium. Usually, the calcium content of the cell membrane is 500 times higher than that of the intracellular calcium. Neuromuscular responses, blood coagulation, cell adhesion, nerve impulse conduction, heart rate maintenance, and cell secretion, contraction, excitation, diffusion, and differentiation all depend on this transmembrane movement. Oyster calcium carbonate is widely used in European and American countries, and has been recorded in Chinese, American, British, and Japanese pharmacopoeias, and it is clinically used as a calcium supplement.
各个阶段人群都需要补充足够的钙。婴幼儿生长发育迅速,是一生中钙代谢的最旺盛阶段,一旦缺钙,则会表现出一系列早期症状,如烦躁、多汗、厌食、夜惊、抽搐等。如不及时纠正早期缺钙状况,会导致自身免疫力下降,不名原因的上呼吸道感染,频发痉挛性腹痛与腹泻,患儿伴有毛发稀少细黄、枕秃、环秃等体征。研究表明,孕期摄入钙偏低(平均每天478毫克)的女性,虽然其肠道对钙的吸收率较高,但其骨密度(以腰椎骨密度为代表)仍明显降低,与同龄非孕女性相比,平均下降了15%。而摄入钙较多(平均每天1274毫克)的孕妇,虽然其肠道对钙的吸收率较低,但其骨密度没有降低,与同龄非孕女性基本相同。这说明,孕期增加钙摄入才是孕妇骨骼健康的基本保障,仅仅靠上述进化机制是远远不够的。而老年人新陈代谢逐渐变缓,消化功能减弱,钙的需要量也相对增加。People at all stages need to supplement enough calcium. Infants and young children grow and develop rapidly, which is the most vigorous stage of calcium metabolism in life. Once calcium deficiency occurs, a series of early symptoms will appear, such as irritability, sweating, anorexia, night terrors, and convulsions. If the early calcium deficiency is not corrected in time, it will lead to decreased autoimmunity, upper respiratory tract infection of unknown cause, frequent spasmodic abdominal pain and diarrhea, and children with thin and yellow hair, pillow baldness, annular baldness and other signs. Studies have shown that women with low calcium intake during pregnancy (an average of 478 mg per day) have a high absorption rate of calcium in their intestines, but their bone density (represented by lumbar spine bone density) is still significantly lower, which is comparable to that of non-pregnant women of the same age. Compared with women, the average drop was 15%. Pregnant women who consume more calcium (1274 mg per day on average), although their intestinal absorption rate of calcium is lower, their bone density does not decrease, which is basically the same as that of non-pregnant women of the same age. This shows that increasing calcium intake during pregnancy is the basic guarantee for the bone health of pregnant women, and the above evolutionary mechanism alone is far from enough. The metabolism of the elderly gradually slows down, the digestive function weakens, and the calcium requirement increases relatively.
补钙效果的优劣,关键在于钙吸收的多少。钙的吸收部位在小肠上段,以十二指肠吸收最快,但吸收量则以较长的回肠为钙的主要吸收场所。钙的吸收方式除少量经扩散作用而吸收外,主要是通过肠粘膜的主动运输来完成。不同年龄吸收率不同:婴幼儿的吸收率最高,为50%-60%;青少年的吸收率则为 35%-40%;成人吸收率更低,为15%-20%;老年人的吸收率仅为10%。药物在血液中的浓度是药物发挥疗效和维持疗效的一个重要条件,也是评价钙补充剂吸收多少的依据。The effect of calcium supplementation depends on how much calcium is absorbed. The absorption site of calcium is in the upper part of the small intestine, and the duodenum absorbs the fastest, but the absorption amount takes the longer ileum as the main absorption site of calcium. The absorption of calcium is mainly through the active transport of the intestinal mucosa, except for a small amount of absorption by diffusion. The absorption rate is different in different ages: the absorption rate of infants is the highest, 50%-60%; the absorption rate of teenagers is 35%-40%; the absorption rate of adults is lower, 15%-20%; the absorption rate of the elderly Only 10%. The concentration of the drug in the blood is an important condition for the drug to exert and maintain its curative effect, and it is also the basis for evaluating the absorption of calcium supplements.
牡蛎碳酸钙是一种常规的补钙剂,用于妊娠和哺乳期妇女、更年期妇女、老年人等的钙补充剂。本品有效成份在水中溶解度极小,在贮存与使用过程中易出现沉淀,此时的钙不是以离子状态存在,需要消耗胃酸解离后才能吸收。这种情况会对胃造成刺激,也会影响钙吸收。《如何正确选择口服钙剂》(《中国农村医学》,1998年第26卷第1期第17页),总结了高质量钙剂应具有的特点,其中包括溶解性能好与生物利用度高。对于本产品,如何提高本品溶解性,减少沉淀,以及保证质量指标稳定性,从而提高本品补钙效果,是药学研究人员一直努力而未解决的问题。Oyster Calcium Carbonate is a regular calcium supplement for pregnant and lactating women, menopausal women, the elderly, etc. The active ingredients of this product have extremely low solubility in water, and are prone to precipitation during storage and use. At this time, calcium does not exist in an ion state, and it needs to be absorbed after being dissociated by gastric acid. This condition can be irritating to the stomach and can also affect calcium absorption. "How to Correctly Choose Oral Calcium Agents" ("China Rural Medicine", 1998, Vol. 26, No. 1, Page 17), summarizes the characteristics that high-quality calcium agents should have, including good solubility and high bioavailability. For this product, how to improve the solubility of this product, reduce precipitation, and ensure the stability of quality indicators, so as to improve the calcium supplement effect of this product, has been an unsolved problem that pharmaceutical researchers have been working hard on.
CN106943427A公开了一种碳酸钙颗粒组合物及其制备方法,以解决现有制剂溶解性不好、容易产生沉淀的问题。该方案组合物,按重量份比计,包括:碳酸钙100份、糖粉3000-4500份、酸源120-180份。该方法包括以下步骤:CN106943427A discloses a calcium carbonate particle composition and a preparation method thereof to solve the problems of poor solubility and easy precipitation of existing preparations. The composition according to the scheme comprises: 100 parts of calcium carbonate, 3000-4500 parts of powdered sugar and 120-180 parts of acid source. The method includes the following steps:
(a)按重量份比计,称量100份碳酸钙、3000-4500份糖粉、120-180份酸源;(a) by weight ratio, weigh 100 parts of calcium carbonate, 3000-4500 parts of powdered sugar, 120-180 parts of acid source;
(b)取100-150份的糖粉加入纯化水配制成质量比浓度为35-65%的糖浆,将所述碳酸钙和糖粉按质量比为100:900-2000混合均匀,然后加入所述糖浆,制成软材,湿法制粒,干燥,整粒,得碳酸钙颗粒;(b) Take 100-150 parts of powdered sugar and add purified water to prepare a syrup with a mass ratio concentration of 35-65%, mix the calcium carbonate and powdered sugar uniformly in a mass ratio of 100:900-2000, and then add the Said syrup is made into soft material, wet granulated, dried, and granulated to obtain calcium carbonate granules;
(c)按质量比为1:0.4-1将酸源和纯化水混合,充分溶解后加入剩余糖粉,制成软材,湿法制粒,干燥,整粒,得到酸颗粒;(c) mix the acid source and purified water according to the mass ratio of 1:0.4-1, add the remaining powdered sugar after fully dissolving, make a soft material, wet granulate, dry, and granulate to obtain acid granules;
(d)将步骤(b)得到的碳酸钙颗粒和步骤(c)得到的酸颗粒混匀即得碳酸钙颗粒组合物。(d) mixing the calcium carbonate granules obtained in step (b) and the acid granules obtained in step (c) to obtain the calcium carbonate granule composition.
上述制备方法,将成品颗粒分成了两部分,分别是碳酸钙颗粒与酸颗粒。碳酸钙颗粒由蔗糖加水制得糖浆,然后与碳酸钙、糖粉制粒而得;酸颗粒由酸加水,然后与剩余蔗糖制粒而得。通过分成两部分颗粒,一定程度上避免了碳酸钙与酸源接触,有利于碳酸钙稳定,提高溶解性,减少沉淀。该发明的技术方案,步骤(c),亦即酸颗粒干燥步骤,采用两种方法:一种是在普通干燥箱中25℃下干燥5-60h;另一种是先用18-26℃的冷风烘干1-20min,然后再40-70℃的热风烘干10-20min,再用18-26℃冷风降温至室温。可见酸颗粒的干燥耗时 很长(25℃下干燥5-60h),或者操作繁琐(先冷风,再热风,最后再冷风干燥),增加了操作难度,增大了生产成本,不利于商业化生产。另外,本发明人对该技术方案重现过程中,发现由该方法制备的样品,存在两方面问题:1.成品含量均匀度较差,这可能与本品主药占比较小(约2.5%),采用两部分制粒,主药不易混合均匀有关;2.进一步加速考察检测结果表明,成品酸度项目有明显升高。In the above preparation method, the finished granules are divided into two parts, namely calcium carbonate granules and acid granules. Calcium carbonate granules are made by adding water to sucrose to make syrup, then granulated with calcium carbonate and powdered sugar; acid granules are made by adding acid to water, and then granulated with the remaining sucrose. By being divided into two parts, the contact between calcium carbonate and acid source is avoided to a certain extent, which is beneficial to the stability of calcium carbonate, improving solubility and reducing precipitation. In the technical scheme of the invention, step (c), that is, the acid particle drying step, adopts two methods: one is to dry for 5-60h at 25°C in a common drying oven; Dry with cold air for 1-20 minutes, then dry with hot air at 40-70°C for 10-20 minutes, then cool down to room temperature with cold air at 18-26°C. It can be seen that the drying of acid particles takes a long time (drying at 25°C for 5-60 hours), or the operation is cumbersome (first cold air, then hot air, and finally cold air drying), which increases the difficulty of operation and increases the production cost, which is not conducive to commercialization Production. In addition, during the process of reproducing the technical solution, the inventors found that the samples prepared by this method had two problems: 1. The content uniformity of the finished product was poor, which may be due to the small proportion of the main drug of this product (about 2.5% ), the use of two-part granulation is related to the fact that the main ingredient is not easy to mix evenly; 2. The results of further accelerated inspection and testing show that the acidity of the finished product has increased significantly.
基于临床应用对本品药学质量要求,以及现有技术存在的缺陷,故有必要进一步研究,以保证产品质量,改善吸收,提高临床应用效果。牡蛎碳酸钙颗粒多采用湿法制粒工艺。具体来讲,可以采用摇摆制粒、剪切制粒、流化床一步制粒,以及不同制粒方式相结合。本发明人在对工艺深入研究过程中,对CN106943427A公开的技术方案进行了改进,将制粒溶剂由纯化水替换为一定浓度乙醇,将柠檬酸溶于乙醇再与蔗糖制粒,发现制得颗粒在烘干时会出现淡黄色,且颜色随着柠檬酸用量增大而加深。根据这一现象,本发明人创造性的将蔗糖与柠檬酸在乙醇溶液中混合,混合后的溶液作为粘合剂,然后再制粒。通过对乙醇浓度、溶解蔗糖的量、以及相应条件进行研究,发现这种制粒方式制备的成品,具有较好的含量均匀度,同时具有溶解性好,沉淀少、pH值稳定的特点。意外的是,通过服用后监测血钙浓度,本工艺制得的成品,具有较好的补钙效果,能够更快提高血钙浓度。Based on the pharmaceutical quality requirements of this product in clinical application and the defects in the existing technology, further research is necessary to ensure product quality, improve absorption, and improve clinical application effects. Oyster calcium carbonate granules mostly adopt wet granulation process. Specifically, rocking granulation, shear granulation, one-step fluidized bed granulation, and a combination of different granulation methods can be used. In the process of in-depth research on the process, the inventor improved the technical solution disclosed in CN106943427A, replaced the granulation solvent with purified water to a certain concentration of ethanol, dissolved citric acid in ethanol and then granulated with sucrose, and found that the obtained granules It will appear light yellow when drying, and the color will deepen with the increase of citric acid dosage. According to this phenomenon, the inventor creatively mixed sucrose and citric acid in ethanol solution, and the mixed solution was used as binder, and then granulated. Through the study of ethanol concentration, the amount of dissolved sucrose, and the corresponding conditions, it was found that the finished product prepared by this granulation method has better content uniformity, good solubility, less precipitation, and stable pH value. Surprisingly, by monitoring the blood calcium concentration after taking it, the finished product made by this process has a better calcium supplement effect and can increase the blood calcium concentration faster.
发明内容Contents of the invention
本发明的目的是提供一种牡蛎碳酸钙颗粒制备方法,该方法采用湿法剪切制粒工艺。该工艺突出实质性特点在于,采用乙醇作溶剂,乙醇中溶解全部处方量柠檬酸,以及特定量蔗糖,溶解时需控制特定温度。The object of the present invention is to provide a kind of preparation method of oyster calcium carbonate particle, this method adopts wet shearing granulation process. The outstanding substantive feature of this process is that ethanol is used as a solvent, and the entire prescription amount of citric acid and a specific amount of sucrose are dissolved in ethanol, and a specific temperature needs to be controlled during the dissolution.
本发明的一种牡蛎碳酸钙颗粒制备方法,包含以下步骤:A kind of preparation method of oyster calcium carbonate particle of the present invention comprises the following steps:
1)将牡蛎碳酸钙、蔗糖粉碎过80-100目筛;1) Oyster calcium carbonate and sucrose are pulverized through a 80-100 mesh sieve;
2)按制粒物料重量6.5%称取浓度为20%-40%的乙醇溶液,将处方量柠檬酸和6.5%-8.5%处方量蔗糖溶解于上述乙醇溶液中,溶解时控制乙醇溶液温度为40℃-60℃,制得溶液A;2) Take by weighing 6.5% of the weight of the granulated material an ethanol solution with a concentration of 20%-40%, and dissolve the prescription amount of citric acid and 6.5%-8.5% of the prescription amount of sucrose in the above-mentioned ethanol solution, and control the temperature of the ethanol solution during dissolution. 40°C-60°C to prepare solution A;
3)将处方量牡蛎碳酸钙和剩余量蔗糖加入湿法制粒机中,搅拌混合均匀,加入步骤2)中的溶液A,剪切制粒;3) Add the prescription amount of oyster calcium carbonate and the remaining amount of sucrose into the wet granulator, stir and mix evenly, add the solution A in step 2), and shear granulate;
4)将制得的颗粒干燥、整粒、分装,即得牡蛎碳酸钙颗粒。4) Drying, sizing and subpackaging the prepared granules to obtain oyster calcium carbonate granules.
本发明进一步优化的技术方案可以是:The further optimized technical scheme of the present invention can be:
1)牡蛎碳酸钙、蔗糖粉碎过100目筛;1) Oyster calcium carbonate and sucrose are crushed through a 100-mesh sieve;
2)乙醇溶液浓度为30%;2) The concentration of ethanol solution is 30%;
3)乙醇溶液溶解处方量7.5%蔗糖;3) Ethanol solution dissolves 7.5% sucrose in prescription quantity;
4)溶解柠檬酸、蔗糖时控制乙醇溶液温度为50℃。4) When dissolving citric acid and sucrose, control the temperature of the ethanol solution to 50°C.
另外,在产品制备过程中,根据剪切制粒后,视制粒物料情况,可再加入适量乙醇溶液再剪切制粒,这是本领域技术人员可以根据经验判断的。In addition, in the process of product preparation, after shear granulation, depending on the condition of the granulated material, an appropriate amount of ethanol solution can be added and then shear granulated, which can be judged by those skilled in the art based on experience.
本发明制备方法,牡蛎碳酸钙颗粒处方含有重量份的:In the preparation method of the present invention, the oyster calcium carbonate granule prescription contains parts by weight:
牡蛎碳酸钙       125份Oyster calcium carbonate 125 servings
蔗糖             4675份-4710份Sucrose 4675-4710 parts
柠檬酸           165份-200份Citric acid 165-200 parts
进一步的,本发明制备方法,牡蛎碳酸钙颗粒处方含有重量份的:Further, in the preparation method of the present invention, the prescription of oyster calcium carbonate granules contains parts by weight:
牡蛎碳酸钙       125份Oyster calcium carbonate 125 servings
蔗糖             4690份Sucrose 4690 parts
柠檬酸           185份Citric acid 185 parts
本发明处方中,还可以含有该种剂型适宜添加的其他药学辅料,包括色素与香精等,如0.1份的柠檬黄、2.5份的桔子香精。The prescription of the present invention may also contain other pharmaceutical excipients suitable for this dosage form, including pigments and essences, such as 0.1 part of tartrazine and 2.5 parts of orange essence.
本发明制备方法中,牡蛎碳酸钙、蔗糖粉碎过80-100目筛,优选100目筛,过筛处理实现对起始物料粒度控制,避免物料结块。当采用其他大小目数筛网,也存在适用可能性,只是会增加产品质量风险,以及增大成本等。柠檬酸与部分蔗糖溶解于乙醇溶液制得的溶液A,在本品的制备过程中,作用为粘合剂。根据研究乙醇溶液的用量为制粒物料重量的6.5%。本发明的制备方法,可在制粒结束后,根据物料状态,补加少量乙醇,再进行制粒。这是药学普通技术人员能够认识到,并且可以判断的问题,并且对本品质量不会产生主要或决定性影响。In the preparation method of the present invention, oyster calcium carbonate and sucrose are pulverized and passed through a sieve of 80-100 mesh, preferably a sieve of 100 mesh, and the sieving treatment realizes the particle size control of the starting material and avoids material agglomeration. When using other sizes of screens, there is also the possibility of application, but it will increase the risk of product quality and increase the cost. Solution A prepared by dissolving citric acid and part of sucrose in ethanol solution acts as a binder during the preparation of this product. According to research, the amount of ethanol solution is 6.5% of the weight of the granulated material. In the preparation method of the present invention, after the granulation is completed, a small amount of ethanol can be added according to the state of the material, and then the granulation can be carried out. This is a problem that can be recognized and judged by ordinary technicians in pharmacy, and it will not have a major or decisive impact on the quality of this product.
下面结合现有技术文献,对本发明所具有的积极效果进行说明:Below in conjunction with prior art literature, the positive effect that the present invention has is described:
牡蛎碳酸钙颗粒处方中,多含酸源,如柠檬酸。碳酸钙为碱性,柠檬酸为酸性,接触即有可能反应,生成柠檬酸钙沉淀。生产过程中避免两者接触,可以减少反应,减少沉淀,进一步的,有助于增加吸收,提高补钙效果。 CN106943427A公开的技术方案,将成品颗粒分成了两部分,分别是碳酸钙颗粒与酸颗粒。通过分成两部分颗粒,一定程度上避免了碳酸钙与酸源接触,有利于碳酸钙稳定,提高溶解性,减少沉淀。本发明采用乙醇作溶剂,创造性的在乙醇中溶解全部处方量柠檬酸,以及部分蔗糖。乙醇浓度经过筛选而得,需控制在20%-40%,优选的乙醇浓度为30%。溶于乙醇中蔗糖的量是经过反复多次筛选而确定的,只有用量达到制粒物料重量的6.5%,才能保证本品的稳定性。当用量低于6.5%时,制得的成品,0天质量无明显区别,但在药品稳定考察过程中,会出现沉淀增多,pH值升高问题。当蔗糖用量高于制粒物料重量8.5%时,会出现蔗糖溶解过程缓慢的问题,不利于工业化生产。本发明的制备方法,优选的溶于乙醇中蔗糖的量为处方量的7.5%。柠檬酸与部分蔗糖溶解于乙醇过程,需控制乙醇温度为40℃-60℃。低于40℃,物料溶解缓慢,不利于生产;高于60℃,制得的颗粒容易出现颜色变化,这在生产过程中,是需要避免的。采用本发明方法制备的成品,减弱了柠檬酸与碳酸钙的作用,从而具有溶解性好,沉淀少、pH值稳定的特点。另外,本方法采用湿法制粒充分混合均匀,成品含量均匀度较好。意外的是,通过服用后监测血钙浓度,能够更快提高血钙浓度,具有较好的补钙效果。对于补钙产品,增加吸收,提高效果,一直都是技术人员不断努力方向。In the prescription of oyster calcium carbonate granules, there are many acid sources, such as citric acid. Calcium carbonate is alkaline, while citric acid is acidic, and they may react upon contact to form calcium citrate precipitates. Avoiding the contact between the two during the production process can reduce the reaction and precipitation, and further help to increase absorption and improve the effect of calcium supplementation. In the technical solution disclosed in CN106943427A, the finished granules are divided into two parts, namely calcium carbonate granules and acid granules. By being divided into two parts, the contact between calcium carbonate and acid source is avoided to a certain extent, which is beneficial to the stability of calcium carbonate, improving solubility and reducing precipitation. The present invention uses ethanol as a solvent, and creatively dissolves the whole prescription amount of citric acid and part of sucrose in ethanol. The ethanol concentration is obtained through screening and needs to be controlled at 20%-40%, and the preferred ethanol concentration is 30%. The amount of sucrose dissolved in ethanol is determined after repeated screening, and the stability of this product can only be guaranteed if the amount reaches 6.5% of the weight of the granulated material. When the dosage is lower than 6.5%, there is no obvious difference in the quality of the finished product at day 0, but in the process of drug stability investigation, there will be problems of increased precipitation and increased pH value. When the amount of sucrose is higher than 8.5% by weight of the granulated material, the problem of slow dissolution process of sucrose will occur, which is not conducive to industrial production. In the preparation method of the present invention, the preferred amount of sucrose dissolved in ethanol is 7.5% of the recipe amount. In the process of dissolving citric acid and part of sucrose in ethanol, the temperature of ethanol needs to be controlled at 40°C-60°C. Below 40°C, the material dissolves slowly, which is not conducive to production; above 60°C, the color of the prepared particles is prone to change, which needs to be avoided during the production process. The finished product prepared by the method of the invention weakens the effect of citric acid and calcium carbonate, thereby having the characteristics of good solubility, less precipitation and stable pH value. In addition, this method adopts wet granulation to fully mix and evenly, and the content uniformity of the finished product is better. Surprisingly, by monitoring the blood calcium concentration after taking it, the blood calcium concentration can be increased faster and has a better calcium supplement effect. For calcium supplement products, increasing absorption and improving effects have always been the direction of continuous efforts of technicians.
本发明技术方案,实质性特征在于将柠檬酸与特定量蔗糖溶解于制粒用醇溶液中,仍采用常规湿法制粒工艺,生产过程简单,操作容易,成本低廉,适合工业化大生产。该制备方法,不仅在药学方面保证了产品质量,而且具有更好的临床应用效果。本发明,对于牡蛎碳酸钙颗粒这个补钙产品,无疑是巨大的技术进步,与现有技术相比,亦具有显著性提高。The technical solution of the present invention is essentially characterized in that citric acid and a specific amount of sucrose are dissolved in an alcoholic solution for granulation, and a conventional wet granulation process is still adopted. The production process is simple, the operation is easy, the cost is low, and it is suitable for large-scale industrial production. The preparation method not only ensures the product quality in pharmacy, but also has better clinical application effect. The present invention is undoubtedly a huge technical progress for the calcium supplement product of oyster calcium carbonate granules, and also has a significant improvement compared with the prior art.
具体实施方式Detailed ways
下面的实施例仅用于进一步详细说明本发明,但不以任何方式限制本发明的范围。The following examples are only used to further illustrate the present invention in detail, but do not limit the scope of the present invention in any way.
实施例1:牡蛎碳酸钙颗粒处方(重量份)Embodiment 1: oyster calcium carbonate granule prescription (parts by weight)
牡蛎碳碳酸钙     125份Oyster carbon calcium carbonate 125 servings
蔗糖             4690份Sucrose 4690 parts
柠檬酸           185份Citric acid 185 parts
制备方法:Preparation:
1)将牡蛎碳酸钙、蔗糖粉碎过100目筛。1) Pulverize oyster calcium carbonate and sucrose through a 100-mesh sieve.
2)按制粒物料重量6.5%称取浓度为30%的乙醇溶液,将处方量柠檬酸和7.5%处方量蔗糖,溶解于乙醇溶液中,溶解时搅拌并加热,控制乙醇溶液温度50℃,制得溶液A。2) Take by weighing 30% ethanol solution with a concentration of 6.5% of the weight of the granulation material, dissolve the prescription amount of citric acid and 7.5% prescription amount of sucrose in the ethanol solution, stir and heat when dissolving, and control the temperature of the ethanol solution to 50°C. Solution A was prepared.
3)将处方量牡蛎碳酸钙和剩余量蔗糖加入高效湿法制粒机中,低速搅拌100秒,混合均匀。然后低速搅拌、高速切削加入步骤2)的溶液A,溶液A加完后高速搅拌及高速切削60秒,即得湿颗粒。3) Add the prescription amount of oyster calcium carbonate and the remaining amount of sucrose into the high-efficiency wet granulator, stir at a low speed for 100 seconds, and mix well. Then add the solution A in step 2) with low-speed stirring and high-speed cutting. After adding solution A, high-speed stirring and high-speed cutting for 60 seconds to obtain wet particles.
4)将制得的颗粒用流化床干燥,干燥时控制进风温度60℃左右;干燥后的颗粒用粉碎式整粒机整粒。4) The prepared granules are dried in a fluidized bed, and the air inlet temperature is controlled at about 60° C. during drying; the dried granules are sized with a pulverizing granulator.
5)用药用复合膜袋密封包装(以钙计50mg/袋),即得牡蛎碳酸钙颗粒。5) Hermetically packaged in a medicinal composite film bag (calculated as calcium 50 mg/bag), to obtain oyster calcium carbonate granules.
实施例2:牡蛎碳酸钙颗粒处方(重量份)Embodiment 2: oyster calcium carbonate granule prescription (parts by weight)
Figure PCTCN2022098166-appb-000001
Figure PCTCN2022098166-appb-000001
1)将牡蛎碳酸钙、蔗糖粉碎过80目筛。1) Pulverize oyster calcium carbonate and sucrose through an 80-mesh sieve.
2)按制粒物料重量6.5%称取浓度为20%的乙醇溶液,将处方量柠檬酸、处方量柠檬黄和处方量6.5%蔗糖,溶解于乙醇溶液中,溶解时搅拌并加热,控制乙醇溶液温度40℃,制得溶液A。2) Take by weighing the 20% ethanol solution with a concentration of 6.5% of the weight of the granulation material, dissolve the prescription amount of citric acid, the prescription amount of tartrazine and the prescription amount of 6.5% sucrose in the ethanol solution, stir and heat when dissolving, and control the ethanol Solution A was prepared at a solution temperature of 40°C.
3)将处方量牡蛎碳酸钙和剩余量蔗糖加入高效湿法制粒机中,低速搅拌100秒,混合均匀。然后低速搅拌、高速切削加入步骤2)的溶液A,溶液A加完后高速搅拌及高速切削60秒,即得湿颗粒。3) Add the prescription amount of oyster calcium carbonate and the remaining amount of sucrose into the high-efficiency wet granulator, stir at a low speed for 100 seconds, and mix well. Then add the solution A in step 2) with low-speed stirring and high-speed cutting. After adding solution A, high-speed stirring and high-speed cutting for 60 seconds to obtain wet particles.
4)将制得的颗粒用流化床干燥,干燥时控制进风温度60℃左右;干燥后的颗粒用粉碎式整粒机整粒。4) The prepared granules are dried in a fluidized bed, and the air inlet temperature is controlled at about 60° C. during drying; the dried granules are sized with a pulverizing granulator.
5)用药用复合膜袋密封包装(以钙计50mg/袋),即得牡蛎碳酸钙颗粒。5) Hermetically packaged in a medicinal composite film bag (calculated as calcium 50 mg/bag), to obtain oyster calcium carbonate granules.
实施例3:牡蛎碳酸钙颗粒处方(重量份)Embodiment 3: oyster calcium carbonate granule prescription (weight part)
Figure PCTCN2022098166-appb-000002
Figure PCTCN2022098166-appb-000002
Figure PCTCN2022098166-appb-000003
Figure PCTCN2022098166-appb-000003
1)将牡蛎碳酸钙、蔗糖粉碎过100目筛。1) Pulverize oyster calcium carbonate and sucrose through a 100-mesh sieve.
2)按制粒物料重量6.5%称取浓度为40%的乙醇溶液,将处方量柠檬酸、处方量桔子香精和处方量8.5%蔗糖,溶解于乙醇溶液中,溶解时搅拌并加热,控制乙醇溶液温度60℃,制得溶液A。2) Take by weighing 40% ethanol solution with a concentration of 6.5% of the weight of the granulation material, dissolve the prescription amount of citric acid, the prescription amount of orange essence and the prescription amount of 8.5% sucrose in the ethanol solution, stir and heat during dissolution, and control the ethanol The solution temperature is 60°C, and the solution A is prepared.
3)将处方量牡蛎碳酸钙和剩余量蔗糖加入高效湿法制粒机中,低速搅拌100秒,混合均匀。然后低速搅拌、高速切削加入步骤2)的溶液A,溶液A加完后高速搅拌及高速切削60秒。制粒完成后,开启低速搅拌、高速切削,再按制粒物料重量1%称取浓度为40%乙醇溶液加入其中,乙醇溶液加完后高速搅拌及高速切削30秒,即得湿颗粒。3) Add the prescription amount of oyster calcium carbonate and the remaining amount of sucrose into the high-efficiency wet granulator, stir at a low speed for 100 seconds, and mix well. Then add solution A in step 2) with low-speed stirring and high-speed cutting, and high-speed stirring and high-speed cutting for 60 seconds after solution A is added. After the granulation is completed, turn on low-speed stirring and high-speed cutting, then weigh 40% ethanol solution according to 1% of the weight of the granulated material and add it, after adding the ethanol solution, high-speed stirring and high-speed cutting for 30 seconds, that is, wet granules.
4)将制得的颗粒用流化床干燥,干燥时控制进风温度60℃左右;干燥后的颗粒用粉碎式整粒机整粒。4) The prepared granules are dried in a fluidized bed, and the air inlet temperature is controlled at about 60° C. during drying; the dried granules are sized with a pulverizing granulator.
5)用药用复合膜袋密封包装(以钙计50mg/袋),即得牡蛎碳酸钙颗粒。5) Hermetically packaged in a medicinal composite film bag (calculated as calcium 50 mg/bag), to obtain oyster calcium carbonate granules.
对比例1:按CN106943427A实施例1公开的内容,制备样品。Comparative Example 1: According to the content disclosed in Example 1 of CN106943427A, a sample was prepared.
1)将牡蛎碳酸钙和蔗糖分别过80目筛,称量过筛后的牡蛎碳酸钙粉末75.2g、过筛后的蔗糖粉2809g、115.8g柠檬酸、0.044g柠檬黄;1) Oyster calcium carbonate and sucrose are passed through an 80-mesh sieve respectively, and 75.2 g of sieved oyster calcium carbonate powder, 2809 g of sieved sucrose powder, 115.8 g of citric acid, and 0.044 g of tartrazine are weighed;
2)取93.5g的蔗糖粉加入纯化水配制成质量比浓度为50%的糖浆,将75.2g过筛后的牡蛎碳酸钙和1425g白砂糖粉放入手工过筛混合3次,然后加入糖浆以及用10g纯化水溶解0.022g色素配制的色素水溶液,制成软材,湿法制粒,50℃干燥120min,整粒,得碳酸钙颗粒;2) Get 93.5g of sucrose powder and add purified water to be mixed with a mass ratio concentration of 50% syrup, put 75.2g of sieved oyster calcium carbonate and 1425g of white granulated sugar powder into manual sieving and mix for 3 times, then add syrup and The pigment aqueous solution prepared by dissolving 0.022g of pigment in 10g of purified water is made into a soft material, wet granulated, dried at 50°C for 120min, and granulated to obtain calcium carbonate granules;
3)将115.8g柠檬酸用47g纯化水混合,充分溶解后加入剩余糖粉以及用10g纯化水溶解0.022g色素配制的色素水溶液,制成软材,湿法制粒,25℃干燥16h,整粒,得酸颗粒。3) Mix 115.8g of citric acid with 47g of purified water, fully dissolve it, add the remaining powdered sugar and dissolve 0.022g of pigment in 10g of purified water to make a soft material, wet granulate, dry at 25°C for 16 hours, and granulate , to get acid particles.
4)将步骤(2)得到的碳酸钙颗粒和步骤(3)得到的酸颗粒混匀。4) Mix the calcium carbonate granules obtained in step (2) and the acid granules obtained in step (3).
5)用药用复合膜袋密封包装(以钙计50mg/袋),即得牡蛎碳酸钙颗粒。5) Hermetically packaged in a medicinal composite film bag (calculated as calcium 50 mg/bag), to obtain oyster calcium carbonate granules.
对比测试:对本发明实施例1-3制备的碳酸钙颗粒成品和对比例制备的碳酸钙颗粒成品进行检测。检测时参照国家药品标准WS-10001-(HD-1037)-2002进行检验。Comparative test: the finished calcium carbonate granules prepared in Examples 1-3 of the present invention and the finished calcium carbonate granules prepared in the comparative examples were detected. When testing, refer to the national drug standard WS-10001-(HD-1037)-2002 for testing.
含量:分别取实施例1-3和对比例1制备的成品各10袋,将颗粒研细,精 密称取适量(约相当于钙50mg),置100ml量瓶中加稀盐酸100ml,振摇使溶解,加活性炭0.1g,充分振摇,用水稀释至刻度,摇匀,滤过,精密量取续滤液50ml,加水50ml,甲基红指示液1滴,滴加氨试液使溶液由红色变为微黄色,加三乙醇胺溶液(1-5)5ml,摇匀,加氢氧化钠试液18ml,钙紫红素指示剂0.2g,用乙二胺四醋酸二钠滴定液(0.05mo1/L)滴定至溶液由紫红色转变为纯蓝色,每1ml的乙二胺四醋酸二钠滴定液(0.05mo1/L)相当于2.004mg的Ca。Content: get respectively 10 bags of finished products prepared in Examples 1-3 and Comparative Example 1, grind the granules finely, accurately weigh an appropriate amount (approximately equivalent to 50 mg of calcium), put in a 100 ml measuring bottle, add 100 ml of dilute hydrochloric acid, and shake to make Dissolve, add 0.1g of activated carbon, shake fully, dilute to the mark with water, shake well, filter, accurately measure 50ml of the subsequent filtrate, add 50ml of water, 1 drop of methyl red indicator solution, add dropwise ammonia test solution to make the solution change from red to If it is slightly yellow, add 5ml of triethanolamine solution (1-5), shake well, add 18ml of sodium hydroxide test solution, 0.2g of calpurin indicator, and use disodium edetate titration solution (0.05mol/L) Titrate until the solution turns from purple red to pure blue, and every 1ml of disodium edetate titration solution (0.05mol/L) is equivalent to 2.004mg of Ca.
酸度:取本品细粉适量(约相当于钙50mg),加水100ml,振摇10分钟,滤过。取滤液,依法测定(中国药典2000年版二部附录VI H),pH值应为4.5-6.5。Acidity: Take an appropriate amount of fine powder of this product (approximately equivalent to 50mg of calcium), add 100ml of water, shake for 10 minutes, and filter. Get filtrate, measure according to law (Chinese Pharmacopoeia edition in 2000 two appendix VI H), pH value should be 4.5-6.5.
溶化性:取本品10g,加热水200ml,搅拌5分钟,应全部溶化或轻微浑浊或混悬均匀,但不得有焦屑等异物。Solubility: Take 10g of this product, heat 200ml of water, stir for 5 minutes, it should be completely dissolved or slightly turbid or evenly suspended, but there should be no foreign matter such as burnt debris.
含量均匀度:取成品10袋,按照含量项检测方法,检查每袋含量,计算RSD。Content uniformity: take 10 bags of the finished product, check the content of each bag according to the detection method of the content item, and calculate the RSD.
(1)0天检测:将实施例1-3制备的碳酸钙颗粒成品和对比例1制备的碳酸钙颗粒成品进行含量、酸度、溶化性、含量均匀度检测,其检测结果见表1。(1) 0-day detection: the calcium carbonate granule finished product prepared by embodiment 1-3 and the calcium carbonate granule finished product prepared by comparative example 1 are tested for content, acidity, solubility, content uniformity, and its test results are shown in Table 1.
表1 实施例1-3及对比例1制备的产品的0天性能检测Table 1 The 0-day performance test of the products prepared in Examples 1-3 and Comparative Example 1
样品sample 含量/%content/% 酸度pHAciditypH 溶化性Solubility 含量均匀度(RSD)Content Uniformity (RSD)
实施例1Example 1 100.2100.2 5.065.06 全部溶化,澄清melt all, clear 0.96%0.96%
实施例2Example 2 99.399.3 5.125.12 全部溶化,澄清melt all, clear 0.83%0.83%
实施例3Example 3 99.899.8 4.834.83 全部溶化,澄清melt all, clear 0.78%0.78%
对比例1Comparative example 1 99.599.5 4.964.96 全部溶化,澄清melt all, clear 4.25%4.25%
结果评价:实施例1-3与对比例1制备的牡蛎碳酸钙颗粒,0天主要检测指标含量、酸度、溶化性没有明显差异;含量均匀度项目,实施例样品明显优于对比例样品。Result evaluation: the oyster calcium carbonate granules prepared by Examples 1-3 and Comparative Example 1 had no significant difference in the main detection index content, acidity, and solubility on day 0; the content uniformity item, the embodiment sample was obviously better than the comparative example sample.
(2)加速3个月检测:将实施例1-3制备的碳酸钙颗粒成品和对比例1制备的碳酸钙颗粒成品,在40℃,湿度75%条件下,加速考察3个月,进行相关检测,其检测结果见表2。(2) Accelerate 3 months detection: with the calcium carbonate granule finished product prepared by embodiment 1-3 and the calcium carbonate granule finished product prepared by comparative example 1, at 40 ℃, under the condition of 75% humidity, accelerate investigation 3 months, carry out correlation The test results are shown in Table 2.
表2 实施例1-3及对比例1制备的产品包装后加速3月检测结果Table 2 Accelerated detection results in three months after the products prepared in Examples 1-3 and Comparative Example 1 were packaged
样品sample 含量/%content/% 酸度acidity 溶化性Solubility
实施例1Example 1 100.5100.5 5.025.02 全部溶化,澄清melt all, clear
实施例2Example 2 99.799.7 5.135.13 全部溶化,澄清melt all, clear
实施例3Example 3 99.199.1 4.854.85 全部溶化,澄清melt all, clear
对比例1Comparative example 1 99.999.9 5.235.23 全部溶化,澄清melt all, clear
结果评价:实施例1-3制备的牡蛎碳酸钙颗粒,加速3月后,批次间主要检测指标没有明显差异,与0天相比,也没有明显变化。对比例1制备的牡蛎碳酸钙颗粒,酸度项目与0天相比,有一定增加。Result evaluation: the oyster calcium carbonate granules prepared in Examples 1-3, after accelerating for 3 months, there is no significant difference in the main detection indicators between batches, and there is no significant change compared with 0 days. For the oyster calcium carbonate particles prepared in Comparative Example 1, the acidity items increased to a certain extent compared with 0 days.
(3)加速6个月检测:将实施例1-3制备的碳酸钙颗粒成品和对比例制备的碳酸钙颗粒成品,在40℃,湿度75%条件下,加速考察6个月,进行相关检测,其检测结果见表3。(3) Accelerate 6 months detection: with the calcium carbonate granule finished product prepared by embodiment 1-3 and the calcium carbonate granule finished product prepared by comparative example, at 40 ℃, under the condition of 75% humidity, accelerate investigation 6 months, carry out relevant detection , and the test results are shown in Table 3.
表3 实施例1-3及对比例1制备的产品包装后加速6月检测结果Table 3 embodiment 1-3 and comparative example 1 preparation product packaging back accelerated testing result in June
样品sample 含量/%content/% 酸度acidity 溶化性Solubility
实施例1Example 1 100.0100.0 5.065.06 全部溶化,澄清melt all, clear
实施例2Example 2 100.2100.2 5.175.17 全部溶化,澄清melt all, clear
实施例3Example 3 99.499.4 4.884.88 全部溶化,澄清melt all, clear
对比例1Comparative example 1 99.199.1 6.066.06 轻微浑浊slightly cloudy
结果评价:实施例1-3制备的牡蛎碳酸钙颗粒,加速6月后,批次间主要检测指标没有明显差异,与0天相比,也没有明显变化。对比例1制备的牡蛎碳酸钙颗粒,酸度项目与0天相比,有明显增加;溶化性项目,也由全部溶化澄清改变为轻微浑浊。Result evaluation: the oyster calcium carbonate granules prepared in Examples 1-3, after accelerating for 6 months, there is no significant difference in the main detection indicators between batches, and there is no significant change compared with the 0 day. For the oyster calcium carbonate granules prepared in Comparative Example 1, the acidity item increased significantly compared with 0 day; the solubility item also changed from all melting clarification to slight turbidity.
根据0天检测结果,实施例样品含量均匀度明显优于对比例样品。根据加速3月与加速6月考察结果,实施例样品与对比例样品相比,具有更好的酸度稳定性,溶化性指标也优于对比例样品。According to the test results on day 0, the content uniformity of the samples of the examples is obviously better than that of the samples of the comparative examples. According to the inspection results of accelerated March and accelerated June, compared with the sample of the comparative example, the sample of the embodiment has better acidity stability, and the solubility index is also better than that of the sample of the comparative example.
补钙剂疗效评价Calcium Supplement Efficacy Evaluation
实施例2与对比例1制备的牡蛎碳酸钙颗粒成品(以钙计50mg/袋),用于补钙人群,监测服用前后血钙浓度,评价临床应用效果。The finished product of oyster calcium carbonate granules (calculated as calcium 50 mg/bag) prepared in Example 2 and Comparative Example 1 is used for calcium supplementation crowds, blood calcium concentration is monitored before and after taking, and clinical application effect is evaluated.
志愿者分组及方法:筛选98例适于补钙,或有补钙需求的人群,随机分为两组,每组49例。Ⅰ组服用实施例2的牡蛎碳酸钙颗粒,Ⅱ组服用对比例1的牡蛎碳酸钙颗粒。两组服用方法相同:口服,一次两袋,一日三次,用温开水冲服。两组连续服用时间均为8周。分别在以下时间点抽取静脉血,作血钙浓度监测,记录数据并分析:服用前、服用4周后、服用6周后、服用8周后。Volunteer grouping and methods: Screen 98 cases who are suitable for calcium supplementation or have calcium supplementation needs, and randomly divide them into two groups, 49 cases in each group. Group I took the oyster calcium carbonate granules of Example 2, and Group II took the oyster calcium carbonate granules of Comparative Example 1. The two groups took the same method: take it orally, two bags at a time, three times a day, and take it with warm water. Both groups were taken continuously for 8 weeks. Venous blood was drawn at the following time points for blood calcium concentration monitoring, and the data was recorded and analyzed: before taking, after taking for 4 weeks, after taking for 6 weeks, and after taking for 8 weeks.
表4 实施例2与对比例1成品服用前后血钙浓度比较
Figure PCTCN2022098166-appb-000004
Table 4 Comparison of blood calcium concentration before and after taking the finished product of Example 2 and Comparative Example 1
Figure PCTCN2022098166-appb-000004
Figure PCTCN2022098166-appb-000005
Figure PCTCN2022098166-appb-000005
Figure PCTCN2022098166-appb-000006
Figure PCTCN2022098166-appb-000006
结果评价:从血钙浓度监测可以看出,服用实施例2的牡蛎碳钙颗粒,每个监测时间点血钙浓度,都高于对比例1的血钙浓度。特别的是,实施例2服用6周的血钙浓度,与对照组1服用8周的血钙浓度,基本接近。因此,本发明的牡蛎碳酸钙颗粒,能够更快提高血钙浓度,具有更好的补钙效果。Result evaluation: From the monitoring of blood calcium concentration, it can be seen that the blood calcium concentration at each monitoring time point is higher than that of Comparative Example 1 after taking the oyster carbon calcium granules of Example 2. In particular, the blood calcium concentration of Example 2 taken for 6 weeks is basically close to that of the control group 1 taken for 8 weeks. Therefore, the oyster calcium carbonate granule of the present invention can increase the blood calcium concentration faster and has a better calcium supplement effect.

Claims (7)

  1. 一种牡蛎碳酸钙颗粒的制备方法,包含以下步骤:A preparation method for oyster calcium carbonate particles, comprising the following steps:
    1)将牡蛎碳酸钙、蔗糖粉碎过80-100目筛;1) Oyster calcium carbonate and sucrose are pulverized through a 80-100 mesh sieve;
    2)按制粒物料重量6.5%称取浓度为20%-40%的乙醇溶液,将处方量柠檬酸和6.5%-8.5%处方量蔗糖溶解于上述乙醇溶液中,溶解时控制所述乙醇溶液温度为40℃-60℃,制得溶液A;2) Take the ethanol solution with a concentration of 20%-40% by weighing 6.5% of the weight of the granulation material, dissolve the prescribed amount of citric acid and 6.5%-8.5% of the prescribed amount of sucrose in the above-mentioned ethanol solution, and control the ethanol solution when dissolving The temperature is 40°C-60°C to prepare solution A;
    3)将处方量牡蛎碳酸钙和剩余量蔗糖加入湿法制粒机中,搅拌混合均匀,加入步骤2)中的溶液A,剪切制粒;3) Add the prescription amount of oyster calcium carbonate and the remaining amount of sucrose into the wet granulator, stir and mix evenly, add the solution A in step 2), and shear granulate;
    4)将制得的颗粒干燥、整粒、分装,即得牡蛎碳酸钙颗粒。4) Drying, sizing and subpackaging the prepared granules to obtain oyster calcium carbonate granules.
  2. 如权利要求1的方法,其特征在于,所述目筛为100目。The method according to claim 1, wherein the mesh sieve is 100 mesh.
  3. 如权利要求1的方法,其特征在于,所述乙醇溶液浓度为30%。The method according to claim 1, characterized in that the concentration of the ethanol solution is 30%.
  4. 如权利要求1的方法,其特征在于,步骤2)中所述蔗糖具体为处方量7.5%。The method according to claim 1, characterized in that the sucrose in step 2) is specifically 7.5% of the prescription amount.
  5. 如权利要求1的方法,其特征在于,所述乙醇溶液温度具体为50℃。The method according to claim 1, characterized in that the temperature of the ethanol solution is specifically 50°C.
  6. 如权利要求1的方法,牡蛎碳酸钙颗粒处方含有重量份的:The method according to claim 1, the oyster calcium carbonate granule prescription contains by weight:
    牡蛎碳酸钙        125份Oyster calcium carbonate 125 servings
    蔗糖              4675份-4710份Sucrose 4675-4710 parts
    柠檬酸            165份-200份Citric acid 165-200 parts
  7. 如权利要求1的方法,牡蛎碳酸钙颗粒处方含有重量份的:The method according to claim 1, the oyster calcium carbonate granule prescription contains by weight:
    牡蛎碳酸钙        125份Oyster calcium carbonate 125 servings
    蔗糖              4690份Sucrose 4690 parts
    柠檬酸            185份Citric acid 185 parts
PCT/CN2022/098166 2021-11-09 2022-06-10 Method for preparing oyster shell calcium granules WO2023082626A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202111321816.0 2021-11-09
CN202111321816.0A CN114010603B (en) 2021-11-09 2021-11-09 Preparation method of oyster calcium carbonate particles

Publications (1)

Publication Number Publication Date
WO2023082626A1 true WO2023082626A1 (en) 2023-05-19

Family

ID=80062750

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2022/098166 WO2023082626A1 (en) 2021-11-09 2022-06-10 Method for preparing oyster shell calcium granules

Country Status (2)

Country Link
CN (1) CN114010603B (en)
WO (1) WO2023082626A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114010603B (en) * 2021-11-09 2023-07-11 重庆华森制药股份有限公司 Preparation method of oyster calcium carbonate particles

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
CN106943427A (en) * 2017-04-12 2017-07-14 华北制药河北华诺有限公司 A kind of calcium carbonate granule composition and preparation method thereof
CN109260220A (en) * 2018-11-28 2019-01-25 重庆华森制药股份有限公司 A kind of preparation method of oyster shell calcium particle
CN114010603A (en) * 2021-11-09 2022-02-08 重庆华森制药股份有限公司 Preparation method of oyster calcium carbonate particles

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5945191B2 (en) * 2012-08-09 2016-07-05 株式会社ファンケル Intraoral quick disintegrating tablet
CN105496983B (en) * 2016-01-21 2018-04-03 国药集团汕头金石制药有限公司 Oyster shell calcium effervescence tablet composition and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
CN106943427A (en) * 2017-04-12 2017-07-14 华北制药河北华诺有限公司 A kind of calcium carbonate granule composition and preparation method thereof
CN109260220A (en) * 2018-11-28 2019-01-25 重庆华森制药股份有限公司 A kind of preparation method of oyster shell calcium particle
CN114010603A (en) * 2021-11-09 2022-02-08 重庆华森制药股份有限公司 Preparation method of oyster calcium carbonate particles

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SONG, LONG; ZHANG, YING; LI, SHUYING; WU, XUEPING; WANG, WENSHENG: "Research Progress of Calcium Carbonate Effervescent Preparation", JOURNAL OF BEIJING UNION UNIVERSITY, vol. 32, no. 2, 30 April 2018 (2018-04-30), pages 36 - 39, XP009546376, ISSN: 1005-0310, DOI: 10.16255/j.cnki.ldxbz.2018.02.006 *

Also Published As

Publication number Publication date
CN114010603A (en) 2022-02-08
CN114010603B (en) 2023-07-11

Similar Documents

Publication Publication Date Title
WO2018077310A1 (en) Vitamin c sodium-containing effervescent tablet and preparation method therefor
CN113713084A (en) Medicine and food dual purpose Chinese medicinal product for treating bone and joint pain and osteoporosis of middle aged and elderly people
CN105943554A (en) Capsule and powder formulations containing lanthanum compounds
CN104068306B (en) Health food for improving bone density and preparation method of health food
CN103462947B (en) Calcium-zinc gluconate granule and method for making thereof
WO2023082626A1 (en) Method for preparing oyster shell calcium granules
CN106943427B (en) Calcium carbonate particle composition and preparation method thereof
CN109260220B (en) Preparation method of oyster calcium carbonate particles
JP2016537429A (en) Ferroporphyrin solid dispersion and method for producing the same
CN110172106A (en) A kind of peach gum polysaccharide iron and its application
CN108815269A (en) Folic acid ferrous gluconate vitamin C effervescent tablet and its preparation method and application
CN105535018A (en) Calcium carbonate D3 granules and preparation method thereof
CN111617042A (en) Composite calcium carbonate vitamin D3Water-free swallow granule and preparation method thereof
CN105533699A (en) Compound for supplementing zinc and vitamin in children as well as preparation method and application thereof
CN113797320A (en) Polypeptide composition for improving anemia symptoms and preparation method thereof
CN114306383A (en) Growth-promoting pharmaceutical composition for improving solubility of calcium hydrogen phosphate and preparation process thereof
CN106387915B (en) Qi and coffee vigor-benefiting effervescent tablet and preparation process and application thereof
CN108635370A (en) A kind of composite preparation and preparation method thereof containing iron-dextrin
CN112675194A (en) Calcium supplement composition
CN111658708A (en) Composition for improving anemia symptoms and preparation method and application thereof
CN109432070A (en) The preparation method and vitaminAD pellet of high uniformity vitaminAD pellet
CN100551361C (en) Influenza defervesce effervescent tablet and preparation method
CN114832020B (en) Pharmaceutical composition for preventing and treating child developmental disorder and preparation method thereof
CN110338425A (en) A kind of nutritional supplement protecting osteoporosis
CN109331039B (en) Composition for improving nutritional anemia and application thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22891435

Country of ref document: EP

Kind code of ref document: A1